Plasmacytoid dendritic cells (PDC) represent a unique secretory cell type that plays a critical role in innate immune responses. PDC respond to virus-associated nucleic acids with a massive secretion of type I interferon (IFN), and therefore are often described as """"""""natural interferon-producing cells"""""""". In addition, PDC are capable of differentiation into conventional antigen-presenting dendritic cells, and of activating a wide range of immune cell types. Because of their IFN-producing capacity, PDC are essential for the control of viral infections, whereas aberrant IFN secretion by PDC appears to be involved in autoimmune diseases. The PDC possess unique cellular and molecular features and gene expression patterns that facilitate their distinct homing and migration pattern, direct recognition of viruses, high-level IFN secretion and differentiation into dendritic cells. However, the molecular mechanisms that regulate lineage commitment, maturation, and function of PDC remain poorly understood. The overall goal of our research is to dissect the regulation of PDC development and function at the molecular level. In preliminary experiments, we identified candidate transcriptional and signaling mechanisms operating in the PDC.
In Specific Aim 1, we will analyze the role of basic helix-loop-helix transcription factors in PDC development and maintenance.
In Specific Aim 2, we will concentrate on Smad-mediated TGFb superfamily signaling in the PDC lineage. Altogether, these studies would elucidate the genetic network governing PDC development and function, and thus pave the way for immunotherapeutic approaches directed at the PDC. PROJECT NARRATIVE: The study is aimed at molecular and genetic analysis of plasmacytoid dendritic cells (PDC), a unique immune cell type that plays a major role in anti-viral immune responses and in autoimmunity. The elucidation of molecular mechanisms that govern PDC development and function would pave the way for novel therapeutic approaches targeting PDC function in infections and autoimmune diseases.
|Sawai, Catherine M; Babovic, Sonja; Upadhaya, Samik et al. (2016) Hematopoietic Stem Cells Are the Major Source of Multilineage Hematopoiesis in Adult Animals. Immunity 45:597-609|
|Spaulding, Emily; Fooksman, David; Moore, Jamie M et al. (2016) STING-Licensed Macrophages Prime Type I IFN Production by Plasmacytoid Dendritic Cells in the Bone Marrow during Severe Plasmodium yoelii Malaria. PLoS Pathog 12:e1005975|
|Ceribelli, Michele; Hou, Zhiying Esther; Kelly, Priscilla N et al. (2016) A Druggable TCF4- and BRD4-Dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm. Cancer Cell 30:764-778|
|Grajkowska, Lucja T; Ceribelli, Michele; Lau, Colleen M et al. (2016) Isoform-Specific Expression and Feedback Regulation of E Protein TCF4 Control Dendritic Cell Lineage Specification. Immunity :|
|Sisirak, Vanja; Sally, Benjamin; D'Agati, Vivette et al. (2016) Digestion of Chromatin in Apoptotic Cell Microparticles Prevents Autoimmunity. Cell 166:88-101|
|Lau, Colleen M; Nish, Simone A; Yogev, Nir et al. (2016) Leukemia-associated activating mutation of Flt3 expands dendritic cells and alters T cell responses. J Exp Med 213:415-31|
|Bunin, Anna; Sisirak, Vanja; Ghosh, Hiyaa S et al. (2015) Protein Tyrosine Phosphatase PTPRS Is an Inhibitory Receptor on Human and Murine Plasmacytoid Dendritic Cells. Immunity 43:277-88|
|Hansen, Lisbeth; Schmidt-Christensen, Anja; Gupta, Shashank et al. (2015) E2-2 Dependent Plasmacytoid Dendritic Cells Control Autoimmune Diabetes. PLoS One 10:e0144090|
|Sisirak, Vanja; Ganguly, Dipyaman; Lewis, Kanako L et al. (2014) Genetic evidence for the role of plasmacytoid dendritic cells in systemic lupus erythematosus. J Exp Med 211:1969-76|
|Ghosh, Hiyaa S; Ceribelli, Michele; Matos, Ines et al. (2014) ETO family protein Mtg16 regulates the balance of dendritic cell subsets by repressing Id2. J Exp Med 211:1623-35|
Showing the most recent 10 out of 24 publications